Merck Provides Update on REVEAL Outcomes Study of Anacetrapib
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Merck & Co. (NYSE: MRK) | Delayed: 149.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.52 | 52 Week High | $65.46 | |||
| Open | $149.52 | 52 Week Low | $47.97 | |||
| Day High | $149.52 | P/E | 101.71 | |||
| Day Low | $149.52 | EPS | $1.47 | |||
| Volume | 2,841 | |||||
